Sponsored By

Foster Delivery Science expands to satisfy demand for drug-delivery polymers

Foster Delivery Science (Putnam, CT), a company that provides hot melt extrusion (HME) services for pharmaceutical and medical device applications, has broken ground on a new facility to support increased demand for drug-delivery and implant polymer blends. The facility is expected to be completed by May 1, 2015, and will be registered with FDA to allow for the processing of active pharmaceutical ingredients (APIs).

PlasticsToday Staff

September 17, 2014

1 Min Read
Foster Delivery Science expands to satisfy demand for drug-delivery polymers

Foster Delivery Science (Putnam, CT), a company that provides hot melt extrusion (HME) services for pharmaceutical and medical device applications, has broken ground on a new facility to support increased demand for drug-delivery and implant polymer blends. The facility is expected to be completed by May 1, 2015, and will be registered with FDA to allow for the processing of active pharmaceutical ingredients (APIs).

The 32,000-sq-ft plant will be dedicated to HME processing of highly regulated materials used for improving bioavailability and release rates of oral dose pharmaceuticals, as well as local delivery of APIs in implantable devices. Foster will offer custom drug/polymer blends in powder form for tablet pressing, or extruded into rods, film, or fiber for a range of drug-delivery applications.

The facility will include a 1200-sq-ft ISO Class 7 cleanroom and a 3500-sq-ft warehouse for storage of APIs, raw materials, intermediates, and finished products.  A comprehensive quality control lab will provide in-house material characterization, including microscopy, thermal analysis, spectroscopy, chromatography, and non-sink dissolution testing.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like